"Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints Are Increasingly Being Applied to Ensure Success" - New Market Report
GBI Research, the leading business intelligence provider, has released its latest research, "Endpoints - Clinical Trials in Autoimmune Disorders - Multiple Primary and Secondary Endpoints are Increasingly Being Applied to Ensure Success" which provides an insight into different endpoints used in clinical trials in autoimmune disorders. The report examines different aspects of clinical trial endpoints in autoimmune disorders, such as analysis of major marketed autoimmune drugs with an emphasis on safety and efficacy details, Phase II and Phase III clinical...
View full press release